WallStreetZenWallStreetZen

NASDAQ: KLRS
Kalaris Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Kalaris Therapeutics revenue was $0.00 for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, KLRS annual revenue was $0.0, with N/A growth year-over-year.

KLRS revenue history

Current Revenue
$0.0
Current Earnings
-$43.9M
Current Profit Margin
0%

Be the first to know when KLRS announces revenue.

KLRS Revenue History By Year

KLRS Yearly RevenueKLRS RevenueKLRS ChangeKLRS Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00-$165.00k-100.00%
2019-12-31$165.00k-$970.00k-85.46%
2018-12-31$1.14MN/AN/A

1 of 1

Kalaris Therapeutics Revenue FAQ

What was KLRS's revenue last quarter?

On Invalid Date, Kalaris Therapeutics (NASDAQ: KLRS) reported Q2 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Kalaris Therapeutics's revenue was $0.00.

What was Kalaris Therapeutics's revenue in 2024?

Kalaris Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Kalaris Therapeutics make in a day?

Based on Kalaris Therapeutics annual revenue for the past five years, KLRS makes an average of $0.00 per day.

What was Kalaris Therapeutics's annual revenue growth in the past year?

As of Q4 2025, Kalaris Therapeutics's revenue has grown null year over year. Kalaris Therapeutics's revenue in the past year totaled $0.00.

How much does Kalaris Therapeutics make in a year?

Kalaris Therapeutics's revenue by year for the past five years is:
  • Kalaris Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Kalaris Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Kalaris Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Kalaris Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Kalaris Therapeutics's annual revenue for 2020 was $0.00, a 100% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.